These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3581713)

  • 1. The effect of cytosine arabinoside on CFU-GM from patients with myelodysplastic syndrome.
    Bailey-Wood R; Clark RE; Dallimore CM; Jacobs A
    Clin Lab Haematol; 1987; 9(1):23-6. PubMed ID: 3581713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosine arabinoside does not cause differentiation in vitro of CFU-GM in marrow from normal, myelodysplastic or ANLL subjects.
    Smith MA; Taylor PC; Smith JG
    Leuk Res; 1990; 14(2):185-93. PubMed ID: 2314114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of rh-cytokines on the sensitivity of normal human CFU-GM progenitors to Ara-C and on the S-phase activity of light density human bone marrow cells.
    Smith MA; Smith JG; Provan AB; Singer CR
    Leuk Res; 1994 Feb; 18(2):105-10. PubMed ID: 7509013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
    Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low dose ARA-C on in-vitro haemopoiesis of marrow cells from myelodysplastic patients.
    Nagler A; Riklis I; Tatarsky I; Fabian I
    Leuk Res; 1987; 11(4):379-84. PubMed ID: 3561019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine arabinoside reduces the numbers of granulocyte macrophage colony forming cells (GM-CFC) and high proliferative potential colony forming cells (HPP-CFC) in vivo in mice.
    Teleka S; Chijuwa A; Senga E; Chisi JE
    Malawi Med J; 2011 Dec; 23(4):118-21. PubMed ID: 23451564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.
    Delforge M; Raets V; Van Duppen V; Boogaerts M
    Leuk Res; 2003 Jul; 27(7):593-8. PubMed ID: 12681358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T; Muus P; Haanen C; Van der Lely N; Koekman E; Van der Locht A; Blankenborg G; Wessels J
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
    Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
    Richman CM; Slapak CA; Toh B
    J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelosuppressive effects of cytosine arabinoside (Ara-C) on growth factor-dependent human long-term bone marrow cultures (LTBMC).
    Kalla P; Oster W; Seiler FR; Rüde E; Krumwieh D
    Int J Cell Cloning; 1992 Jan; 10(1):54-62. PubMed ID: 1552225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
    Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
    Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
    Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY; Chiu WF; Lee CT
    Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.
    Baines P; Bowen D; Jacobs A
    Leuk Res; 1990; 14(3):247-53. PubMed ID: 1690828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow stromal dysfunction in mice administered cytosine arabinoside.
    Ben-Ishay Z; Barak V
    Eur J Haematol; 2001 Apr; 66(4):230-7. PubMed ID: 11380602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of CFU-GM (colony forming units for granulocytes and macrophages) from intact and pinealectomized rat bone marrow to murine recombinant interleukin-3 (rIl-3), recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and human recombinant erythropoietin (rEPO).
    Haldar C; Häussler D; Gupta D
    Prog Brain Res; 1992; 91():323-5. PubMed ID: 1410417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.